It’s been a rough year for General Motors. The company has recalled more than 28 million vehicles worldwide and is liable for billions of dollars in automotive repairs and victim compensation. It suffered an 85% drop in its second-quarter earnings and faces multiple state investigations, not to mention class-action lawsuits related to safety issues. Can GM recover from this massive crisis?
It can make a comeback, but the recovery hinges on changing the organization’s culture. For years, GM focused on cost-effectiveness and the bottom line, creating what the new CEO Mary Barra calls “a pattern of incompetence and neglect.” To address the current crisis, she of course needs to fix the safety problems, but she also needs to create a new company culture. Safety must become the priority over cost savings in order to regain consumer and market trust, and GM’s focus needs to be on the customer.
So far, Barra, who inherited the crisis when she was promoted to CEO this past January, is moving in the right direction. By firing 15 employees who were involved in the lack of communication about safety issues, she sent a powerful message both within and outside of the company about the company’s changing priorities.
MIT Sloan Lecturer Ben Shields, the former director of social media and marketing at ESPN and co-author of The Sports Strategist, talks about deflate-gate, the investigation into whether the New England Patriots used deflated footballs in the Jan. 18 AFC championship game. Shields explains why the Patriots are prone to negative press and social media backlash and what the organization should do as a result.
It’s easy to catch the technology bug. After all, tech companies are pretty much everywhere. I became hooked when I worked as an IT consultant at Accenture after college, and plan to work at a technology company after I finish my MBA. So when I had the opportunity to participate in a Technology Trek at MIT, I jumped at the chance of visiting some of the leading market players recognized globally for their entrepreneurial and technological innovation.
I was very curious about what it’s like to work at a larger technology company, especially big ones with more resources like Facebook and Google. What is their culture really like? What kind of impact can a recent MBA graduate make? During our Technology Trek last week with 27 other MIT Sloan MBA students, I was able to get some answers.
First up was Google’s Mountain View campus. I had never seen it before, and was taken by the size of campus, the people I met, and the general atmosphere. In addition to the famous Google bikes that employees use to get around, we also saw the Wellness Center complete with nap rooms, yoga studios, and a juice bar. During our tour, we learned that Google is opening new offices just a few miles away. It’s pretty big now, but soon it will double in size!
Ben Shields, former Director of Social Media and Marketing at ESPN and co-author of The Sports Strategist, took over the @MITSloanExperts Twitter account on December 17, from 5 p.m. to 6 p.m. to answer questions on the role of social media in professional sports marketing.
This talk was given at a local TEDx event, produced independently of the TED Conferences. Ayesha Khalid, surgeon at Harvard Medical School and recent MBA from the MIT Sloan Fellows Program, is at the intersection of disruptive innovation in healthcare and the digital health experience. Ayesha previously pioneered groundbreaking research in sinus disease including muco-ciliary clearance and outcomes following surgery. She is now a passionate believer that disruptive innovation in healthcare requires collaboration, not competition. Using a systems thinking approach, Ayesha wants us to suspend our belief that adding more process to our healthcare system will add back “health” and “care” to a broken system. Instead, this compelling talk provides an imaginative way to approach the redesign of our health care system to one that promotes “health” and works “systematically” for the patient.
A sinus surgeon at Harvard Medical School and recent MBA graduate from MIT, Ayesha Khalid is a healthcare innovation enthusiast involved with entrepreneurial ventures at the intersection of healthcare innovation and digital technologies. She has pioneered groundbreaking research techniques in inflammation and sinus disease and is working to create different funding paradigms to accelerate clinical research.
For more information, see this op-ed about Dr. Khalid’s approach to reshaping the healthcare system in Huffington Post UK.
Ayesha Khalid is a surgeon at Harvard Medical School and recent MBA graduate from the MIT Sloan Fellows Program.